Private enterprise has moved into human genetics and biotechnology in a way not seen before in any area of science. Research which would once have been regarded as basic, not-for-profit science - a public good in all the senses of the word - is now conducted by big pharmaceutical companies or by biotechnology start-ups, which patent the research results. What would once have been given freely to the entire scientific community has become private intellectual property.